Want to see JP:4927 full AI Analyst Report?
4927 Stock Chart & Stats
¥1392.50
¥20.50(1.53%)
At close: 4:00 PM EDT
¥1392.50
¥20.50(1.53%)
Day’s Range― - ―
52-Week Range¥1,233.00 - ¥1,445.00
Previous CloseN/A
Volume727.40K
Average Volume (3M)416.34K
Market Cap
¥318.46B
Enterprise Value¥219.54B
Total Cash (Recent Filing)¥60.75B
Total Debt (Recent Filing)¥41.00M
Price to Earnings (P/E)27.6
Beta0.38
Next Earnings
Nov 09, 2026EPS Estimate
11.35Next Dividend Ex-DateN/A
Dividend Yield3.66%
Share Statistics
EPS (TTM)29.06
Shares Outstanding229,136,150
10 Day Avg. Volume364,920
30 Day Avg. Volume416,340
Financial Highlights & Ratios
PEG Ratio15.20
Price to Book (P/B)1.77
Price to Sales (P/S)1.69
P/FCF Ratio18.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,354.29Price Target Upside-2.74% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering7
EPS Forecast (FY)48.54
Revenue Forecast (FY)¥172.34B
Bulls Say, Bears Say
Bulls Say
Very Low LeverageExtremely low leverage gives Pola Orbis substantial financial flexibility and resilience through demand cycles. The large equity base reduces solvency pressure and leaves the group better positioned to sustain investment, absorb volatility, and allocate capital without relying heavily on borrowing.
Strong Gross MarginsA gross margin near 78% indicates meaningful economics in the group’s cosmetics portfolio and supports continued funding for brand development, products, and distribution. Maintaining this level of product profitability can help preserve earnings resilience even when revenue growth is limited.
Positive Recent Cash GenerationThe return to substantial operating and free cash flow in 2025 demonstrates that the business can generate cash to support operations and capital allocation. This strengthens financial self-funding capacity, although the broader history shows that consistency remains important.
Bears Say
Limited Revenue GrowthBroadly flat revenue signals limited top-line momentum across the group and reduces the operating leverage available from its brand portfolio. Without sustained sales expansion, future earnings growth may depend more heavily on cost control, mix, or margin initiatives rather than market growth.
Uneven Cash-Flow ConversionUneven conversion of reported earnings into cash lowers confidence in the consistency of underlying cash earnings. The 2025 decline in operating-cash-flow conversion and prior negative free cash flow suggest that cash generation may fluctuate, complicating dependable reinvestment and capital allocation.
Moderating Operating ReturnsOperating profitability has not shown consistent improvement, with EBIT margin below its 2021 level and net margins settling in the mid-single digits. This indicates that strong gross margins have not translated into steadily rising operating returns, limiting earnings expansion from efficiency alone.
Pola Orbis Holdings News
4927 FAQ
What was Pola Orbis Holdings Inc.’s price range in the past 12 months?
Pola Orbis Holdings Inc. lowest stock price was ¥1233.00 and its highest was ¥1445.00 in the past 12 months.
What is Pola Orbis Holdings Inc.’s market cap?
Pola Orbis Holdings Inc.’s market cap is ¥318.46B.
When is Pola Orbis Holdings Inc.’s upcoming earnings report date?
Pola Orbis Holdings Inc.’s upcoming earnings report date is Nov 09, 2026 which is in 17 days.
How were Pola Orbis Holdings Inc.’s earnings last quarter?
Pola Orbis Holdings Inc. released its earnings results on Aug 06, 2026. The company reported ¥18.42 earnings per share for the quarter, beating the consensus estimate of ¥13.47 by ¥4.95.
Is Pola Orbis Holdings Inc. overvalued?
According to Wall Street analysts Pola Orbis Holdings Inc.’s price is currently Overvalued.
Does Pola Orbis Holdings Inc. pay dividends?
Pola Orbis Holdings Inc. pays a Semiannually dividend of ¥31 which represents an annual dividend yield of 3.66%. See more information on Pola Orbis Holdings Inc. dividends here
What is Pola Orbis Holdings Inc.’s EPS estimate?
Pola Orbis Holdings Inc.’s EPS estimate is 11.35.
How many shares outstanding does Pola Orbis Holdings Inc. have?
Pola Orbis Holdings Inc. has 229,136,150 shares outstanding.
What happened to Pola Orbis Holdings Inc.’s price movement after its last earnings report?
Pola Orbis Holdings Inc. reported an EPS of ¥18.42 in its last earnings report, beating expectations of ¥13.47. Following the earnings report the stock price went up 3.008%.
Which hedge fund is a major shareholder of Pola Orbis Holdings Inc.?
Currently, no hedge funds are holding shares in JP:4927
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pola Orbis Holdings Inc.
Pola Orbis Holdings Inc. is a Japanese corporation engaged in the global development, manufacturing, and sale of beauty products and related goods. The company operates primarily through its Beauty Care and Real Estate divisions. Its Beauty Care segment encompasses a broad selection of cosmetics, skincare items, health foods, and fashion accessories, including women's apparel, lingerie, and jewelry, marketed under various brands such as POLA, ORBIS, Jurlique, H2O PLUS, THREE, DECENCIA, Amplitude, ITRIM, FIVEISM × THREE, and FUJIMI. The Real Estate division manages the leasing of commercial and residential properties, in addition to building management and operations. Pola Orbis distributes its products via multiple channels, including department stores, its own retail outlets, duty-free shops, e-commerce platforms, specialized cosmetics stores, direct-to-consumer sales, and mail order. Founded in 1929, the company is headquartered in Tokyo, Japan.
4927 Company Deck
4927 Earnings Call
Q2 2026
0:00 / 0:00
4927 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
¥1,354.29
▼(-2.74% Downside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Kao
―
Kose
―
Rohto Pharmaceutical Co
―
Shiseido Company,Limited
―
Noevir Holdings Co., Ltd.
―









